CereVasc Secures $85 Million in Latest Series C Funding Round

CereVasc secured $85 million in its latest Series C, adding another data point to the Healthcare & Life Sciences funding market.

CereVasc Raises $85 million in Funding

CereVasc is a Digital Health company focused on support eShunt system with investment from J&J, Medtronic.

Investors Behind the Funding

The round was backed by J&J. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

CereVasc operates in Healthcare & Life Sciences. CereVasc's Series C round shows investors are still backing digital health platforms with real scale narratives. At $85M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

support eShunt system with investment from J&J, Medtronic

Looking Ahead

CereVasc closes $85M Series C to support eShunt system with investment from J&J, Medtronic

Source reference: original announcement/article.